Get the Stockscreener App
2.06
4.83%
0.095
After Hours:
2.06
Fractyl Health Inc stock is traded at $2.06, with a volume of 318.61K.
It is up +4.83% in the last 24 hours and down -17.27% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$1.965
Open:
$2
24h Volume:
318.61K
Relative Volume:
0.87
Market Cap:
$98.25M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-17.93%
1M Performance:
-17.27%
6M Performance:
-70.82%
1Y Performance:
+0.00%
1-Day Range:
$1.91
$2.14
1-Week Range:
$1.91
$2.70
52-Week Range:
$1.74
$13.99
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| GUTS | 2.06 | 98.25M | 0 | -56.85M | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
Fractyl Health Inc Stock (GUTS) Latest News
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023) - Yahoo Finance
Fractyl Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Fractyl Health president sells $158,540 in stock By Investing.com - Investing.com Canada
Fractyl Health president sells $158,540 in stock - Investing.com
Fractyl Health CEO sells shares worth $238,358 By Investing.com - Investing.com UK
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
TSX Real Estate Capped Index (TTRE) QuotePress Release - The Globe and Mail
TSX Composite Dividend Index (TXDC) QuotePress Release - The Globe and Mail
S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Fractyl Health Q3: Obesity Treatment Progress Despite Widening Losses; $84.7M Cash Runway | GUTS Stock News - StockTitan
Fractyl Health (GUTS) Scheduled to Post Earnings on Tuesday - Defense World
Fractyl Health (GUTS) Set to Announce Earnings on Tuesday - MarketBeat
Fractyl Health nominates GIP/GLP-1 dual agonist as pancreatic gene therapy candidate for obesity - BioWorld Online
Fractyl Health to Present New Preclinical Data on Sustained - GlobeNewswire
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024 - ForexTV.com
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar - The Bakersfield Californian
Fractyl Health Presented New Analysis from Pooled Data of - GlobeNewswire
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024 - StockTitan
SG Americas Securities LLC Invests $33,000 in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire Inc.
Fractyl Health to Present Compelling Weight Maintenance - GlobeNewswire
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva - The Bakersfield Californian
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024 - StockTitan
14,200 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Bought by Renaissance Technologies LLC - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Increase in Short Interest - MarketBeat
Fractyl Health To Debut On Nasdaq Today - RTTNews
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Financial Fitness Check: Examining Fractyl Health Inc. (GUTS)’s Key Ratios - The Dwinnex
Fractyl Health Inc. (GUTS)’s stock price in review: A technical analysis - US Post News
Massachusetts Financial Services Co. MA Acquires 25,829 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health president sells over $188k in company stock By Investing.com - Investing.com Canada
Fractyl Health president sells over $188k in company stock - Investing.com India
Jay David Caplan Sells 65,000 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock - MarketBeat
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Fractyl Health stock down 8% following $110M IPO - MSN
Fractyl Health to Participate in Upcoming September Investor Conferences - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 13.2% in August - MarketBeat
Fractyl Health Inc. (GUTS) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Fractyl Health Inc. (GUTS) can make a big difference with a little luck - SETE News
Fractyl Health Inc. (GUTS) presents a great opportunity, but the stock is slightly undervalued - US Post News
Stock Performance Spotlight: Fractyl Health Inc. (GUTS) Ends the Day at 3.58, Up by 6.23 - The Dwinnex
Investing in Fractyl Health Inc. (GUTS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Fractyl Health Inc. (GUTS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 5.7% - MarketBeat
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):